Leung Kam
National Center for Biotechnology Information, NLM, NIH, Bethesda, MD
Optical fluorescence imaging is increasingly used to monitor biological functions of specific targets in small animals (1-3). However, the intrinsic fluorescence of biomolecules poses a problem when fluorophores that absorb visible light (350–700 nm) are used. Near-infrared (NIR) fluorescence (700–1,000 nm) detection avoids the natural background fluorescence interference of biomolecules, providing a high contrast between target and background tissues. NIR fluorophores have a wider dynamic range and minimal background fluorescence as a result of reduced scattering compared with visible fluorescence detection. NIR fluorophores also have high sensitivity, resulting from low background fluorescence, and high extinction coefficients, which provide high quantum yields. The NIR region is also compatible with solid-state optical components, such as diode lasers and silicon detectors. NIR fluorescence imaging is a noninvasive alternative to radionuclide imaging in small animals or with probes in close proximity to the target in humans (4, 5). Among the various optical imaging agents, only indocyanine green (ICG), with NIR fluorescence absorption at 780 nm and emission at 820 nm, is approved by the United States Food and Drug Administration for clinical applications in angiography, blood flow evaluation, and liver function assessment. It is also under evaluation in several clinical trials for other applications, such as optical imaging and mapping of both the lymphatic vessels and lymph nodes in cancer patients for surgical dissection of tumors and endoscopic imaging of the pancreas and colon. The primary function of the lymphatic system is to drain ~10% of the interstitial fluid from small capillaries to lymphatic vessels through lymph nodes and finally to the venous system (6-10). Lymph nodes form a natural filter for the lymphatic drainage and prevent the possible migration of cancer cells from the lymphatic system into the body. Serum proteins and macromolecules can be taken up by the large openings in the lymphatic capillaries. However, an accumulation of protein molecules may impair lymphatic flow and cause lymphedema and tissue edema. For NIR fluorescence imaging, ICG has been used in lymphatic imaging because of its association with serum proteins. However, ICG is degraded in aqueous conditions with a half-life of ~20 h and is sensitive to light (half-life, 2.3 h). IRDye 800CW (IRDye800) is an indocyanine-type NIR fluorophore with peak absorption at 785 nm and peak excitation emission at 803 nm, and it is about four-fold brighter than ICG. Dennis et al. (11) identified the peptide Ac-RLIEDICLPRWGCLWEDD (SA21), which bound with high affinity to human and murine serum albumin. Davies-Venn et al. (12) prepared a cyclic version of SA21 called cyclic albumin-binding domain (Ac-RLIEDICLPRWGCLWEDDK-NH, cABD) and conjugated this with IRDye800 to form IRDye800-cABD for NIR fluorescence lymphatic imaging in mice.
光学荧光成像越来越多地用于监测小动物体内特定靶点的生物学功能(1-3)。然而,当使用吸收可见光(350-700nm)的荧光团时,生物分子的固有荧光会带来问题。近红外(NIR)荧光(700-1000nm)检测可避免生物分子的天然背景荧光干扰,使靶组织与背景组织之间具有高对比度。与可见光荧光检测相比,近红外荧光团由于散射减少,具有更宽的动态范围和最小的背景荧光。近红外荧光团还具有高灵敏度,这源于低背景荧光,以及高消光系数,可提供高量子产率。近红外区域也与固态光学组件兼容,如二极管激光器和硅探测器。近红外荧光成像在小动物中是放射性核素成像的非侵入性替代方法,或在人体中用于靠近靶点的探针(4,5)。在各种光学成像剂中,只有吲哚菁绿(ICG)在780nm处吸收近红外荧光,在820nm处发射荧光,已被美国食品药品监督管理局批准用于血管造影、血流评估和肝功能评估的临床应用。它也正在几项临床试验中接受评估,用于其他应用,如癌症患者淋巴管和淋巴结的光学成像和测绘,以进行肿瘤手术切除以及胰腺和结肠的内镜成像。淋巴系统的主要功能是将约10%的组织间液从小毛细血管通过淋巴结引流到淋巴管,最终引流到静脉系统(6-10)。淋巴结形成淋巴引流的天然过滤器,防止癌细胞从淋巴系统迁移到体内。血清蛋白和大分子可被淋巴毛细血管中的大开口吸收。然而,蛋白质分子的积累可能会损害淋巴流动,导致淋巴水肿和组织水肿。对于近红外荧光成像,ICG已用于淋巴成像,因为它与血清蛋白相关。然而,ICG在水性条件下会降解,半衰期约为20小时,并且对光敏感(半衰期为2.3小时)。IRDye 800CW(IRDye800)是一种吲哚菁型近红外荧光团,峰值吸收在785nm,峰值激发发射在803nm,其亮度约为ICG的四倍。丹尼斯等人(11)鉴定出肽Ac-RLIEDICLPRWGCLWEDD(SA21),它与人及小鼠血清白蛋白具有高亲和力结合。戴维斯-文等人(12)制备了一种名为环状白蛋白结合域(Ac-RLIEDICLPRWGCLWEDDK-NH,cABD)的SA21环状版本,并将其与IRDye800偶联,形成IRDye800-cABD用于小鼠近红外荧光淋巴成像。